Martin Markowitz

27.2k total citations · 7 hit papers
85 papers, 20.1k citations indexed

About

Martin Markowitz is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Martin Markowitz has authored 85 papers receiving a total of 20.1k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Virology, 72 papers in Infectious Diseases and 14 papers in Immunology. Recurrent topics in Martin Markowitz's work include HIV Research and Treatment (82 papers), HIV/AIDS drug development and treatment (61 papers) and HIV/AIDS Research and Interventions (55 papers). Martin Markowitz is often cited by papers focused on HIV Research and Treatment (82 papers), HIV/AIDS drug development and treatment (61 papers) and HIV/AIDS Research and Interventions (55 papers). Martin Markowitz collaborates with scholars based in United States, Canada and Germany. Martin Markowitz's co-authors include David D. Ho, Alan S. Perelson, John M. Leonard, Avidan U. Neumann, Arlene Hurley, Wen Chen, Mika Vesanen, Kalle Saksela, Bharat Ramratnam and Linqi Zhang and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Martin Markowitz

85 papers receiving 19.5k citations

Hit Papers

Rapid turnover of plasma virions and CD4 lymphocytes in H... 1995 2026 2005 2015 1995 1996 1997 1997 1998 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
    1995 3.3k citations David D. Ho, Avidan U. Neumann et al. Nature profile →
  2. HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
    1996 2.6k citations Alan S. Perelson, Avidan U. Neumann et al. Science profile →
  3. Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
    1997 2.4k citations Joseph B. Margolick, Joel E. Gallant et al. Science profile →
  4. Decay characteristics of HIV-1-infected compartments during combination therapy
    1997 1.5k citations Alan S. Perelson, Mika Vesanen et al. Nature profile →
  5. Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA
    1998 1.2k citations Graham S. Ogg, Xia Jin et al. Science profile →
  6. Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral Therapy
    1999 691 citations Linqi Zhang, Bharat Ramratnam et al. New England Journal of Medicine profile →
  7. Ordered accumulation of mutations in HIV protease confers resistance to ritonavir
    1996 601 citations Akhteruzzaman Molla, Marina Korneyeva et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Markowitz United States 51 16.5k 12.5k 5.5k 3.5k 1.9k 85 20.1k
John M. Leonard United States 40 9.4k 0.6× 8.4k 0.7× 2.5k 0.5× 2.9k 0.8× 1.2k 0.7× 72 13.8k
Huldrych F. Günthard Switzerland 72 13.7k 0.8× 13.2k 1.1× 3.0k 0.5× 4.3k 1.2× 805 0.4× 371 19.3k
Robert F. Siliciano United States 90 26.2k 1.6× 17.2k 1.4× 11.6k 2.1× 5.6k 1.6× 1.5k 0.8× 308 31.5k
Bette Korber United States 82 17.1k 1.0× 10.8k 0.9× 7.8k 1.4× 4.7k 1.3× 837 0.4× 257 22.7k
John W. Mellors United States 75 19.1k 1.2× 18.2k 1.4× 3.5k 0.6× 4.5k 1.3× 745 0.4× 408 24.9k
Charles R. Rinaldo United States 66 9.4k 0.6× 8.0k 0.6× 6.6k 1.2× 7.2k 2.1× 805 0.4× 347 19.6k
Sharon R. Lewin Australia 67 9.9k 0.6× 8.0k 0.6× 5.8k 1.1× 6.6k 1.9× 903 0.5× 370 19.0k
Avidan U. Neumann Israel 50 7.6k 0.5× 5.5k 0.4× 4.1k 0.7× 5.8k 1.7× 2.0k 1.1× 149 16.7k
Linqi Zhang China 53 7.1k 0.4× 10.9k 0.9× 4.9k 0.9× 3.1k 0.9× 675 0.4× 229 18.2k
Jan Albert Sweden 62 9.5k 0.6× 7.7k 0.6× 2.7k 0.5× 3.2k 0.9× 577 0.3× 274 13.0k

Countries citing papers authored by Martin Markowitz

Since Specialization
Citations

This map shows the geographic impact of Martin Markowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Markowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Markowitz more than expected).

Fields of papers citing papers by Martin Markowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Markowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Markowitz. The network helps show where Martin Markowitz may publish in the future.

Co-authorship network of co-authors of Martin Markowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Markowitz. A scholar is included among the top collaborators of Martin Markowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Markowitz. Martin Markowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Markowitz, Martin & Jay A. Grobler. (2019). Islatravir for the treatment and prevention of infection with the human immunodeficiency virus type 1. Current Opinion in HIV and AIDS. 15(1). 27–32. 41 indexed citations
2.
Mohri, Hiroshi, Nicole Prada, & Martin Markowitz. (2015). Viral Envelope Is a Major Determinant of Enhanced Fitness of a Multidrug-Resistant HIV-1 Variant. JAIDS Journal of Acquired Immune Deficiency Syndromes. 68(5). 487–494. 1 indexed citations
3.
4.
Vaida, Florin, Joel E. Gallant, Karin Ernström, et al.. (2009). Tolerability and Efficacy of PI Versus NNRTI-Based Regimens in Subjects Receiving HAART During Acute or Early HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 50(3). 267–275. 9 indexed citations
5.
Shet, Anita, Barun Mathema, José R. Mediavilla, et al.. (2009). Colonization and Subsequent Skin and Soft Tissue Infection Due to Methicillin‐ResistantStaphylococcusaureusin a Cohort of Otherwise Healthy Adults Infected with HIV Type 1. The Journal of Infectious Diseases. 200(1). 88–93. 64 indexed citations
6.
Markowitz, Martin, Leonard N. Slater, Robert A. Schwartz, et al.. (2007). Long-Term Efficacy and Safety of Tipranavir Boosted With Ritonavir in HIV-1-Infected Patients Failing Multiple Protease Inhibitor Regimens. JAIDS Journal of Acquired Immune Deficiency Syndromes. 45(4). 401–410. 16 indexed citations
7.
Mehandru, Saurabh, Brigitta Vcelar, Terri Wrin, et al.. (2007). Adjunctive Passive Immunotherapy in Human Immunodeficiency Virus Type 1-Infected Individuals Treated with Antiviral Therapy during Acute and Early Infection. Journal of Virology. 81(20). 11016–11031. 88 indexed citations
8.
Clotet, Bonaventura, Jean‐Michel Molina, David A. Cooper, et al.. (2007). Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials. The Lancet. 369(9568). 1169–1178. 367 indexed citations
9.
Shet, Anita, Leslie R. Berry, Hiroshi Mohri, et al.. (2006). Tracking the Prevalence of Transmitted Antiretroviral Drug-Resistant HIV-1. JAIDS Journal of Acquired Immune Deficiency Syndromes. 41(4). 439–446. 133 indexed citations
10.
11.
Mohri, Hiroshi, Alan S. Perelson, Ruy M. Ribeiro, et al.. (2001). Increased Turnover of T Lymphocytes in HIV-1 Infection and Its Reduction by Antiretroviral Therapy. The Journal of Experimental Medicine. 194(9). 1277–1288. 293 indexed citations
12.
Ramratnam, Bharat, John E. Mittler, Linqi Zhang, et al.. (2000). The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy. Nature Medicine. 6(1). 82–85. 377 indexed citations
13.
Ogg, Graham S., Xia Jin, Sebastian Bonhoeffer, et al.. (1999). Decay Kinetics of Human Immunodeficiency Virus-Specific Effector Cytotoxic T Lymphocytes after Combination Antiretroviral Therapy. Journal of Virology. 73(1). 797–800. 292 indexed citations
14.
Boden, Daniel & Martin Markowitz. (1998). Resistance to Human Immunodeficiency Virus Type 1 Protease Inhibitors. Antimicrobial Agents and Chemotherapy. 42(11). 2775–2783. 166 indexed citations
15.
Ogg, Graham S., Xia Jin, Sebastian Bonhoeffer, et al.. (1998). Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA. Science. 279(5359). 2103–2106. 1181 indexed citations breakdown →
16.
Perelson, Alan S., Mika Vesanen, Arlene Hurley, et al.. (1997). Decay characteristics of HIV-1-infected compartments during combination therapy. Nature. 387(6629). 188–191. 1466 indexed citations breakdown →
17.
Molla, Akhteruzzaman, Marina Korneyeva, Qing Gao, et al.. (1996). Ordered accumulation of mutations in HIV protease confers resistance to ritonavir. Nature Medicine. 2(7). 760–766. 601 indexed citations breakdown →
18.
Markowitz, Martin, Michael S. Saag, William G. Powderly, et al.. (1995). A Preliminary Study of Ritonavir, an Inhibitor of HIV-1 Protease, to Treat HIV-1 Infection. New England Journal of Medicine. 333(23). 1534–1540. 403 indexed citations
19.
Markowitz, Martin, Hongmei Mo, Dale J. Kempf, et al.. (1995). Selection and analysis of human immunodeficiency virus type 1 variants with increased resistance to ABT-538, a novel protease inhibitor. Journal of Virology. 69(2). 701–706. 189 indexed citations
20.
Ho, David D., Avidan U. Neumann, Alan S. Perelson, et al.. (1995). Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 373(6510). 123–126. 3320 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John M. Leonard Breakdown of academic impact, for papers by Huldrych F. Günthard Breakdown of academic impact, for papers by Robert F. Siliciano Breakdown of academic impact, for papers by Bette Korber Breakdown of academic impact, for papers by John W. Mellors Breakdown of academic impact, for papers by Charles R. Rinaldo Breakdown of academic impact, for papers by Sharon R. Lewin Breakdown of academic impact, for papers by Avidan U. Neumann Breakdown of academic impact, for papers by Linqi Zhang Breakdown of academic impact, for papers by Jan Albert
Rankless by CCL
2026